Good Morning,

We are pleased to announce that we are collaborating with Day Kimball Hospital, to hold a COVID vaccine clinic on Thursday, March 4. To ensure a steady even flow of staff through the vaccine process we will be scheduling blocks of time and will be letting you know what time you should report to the Middle School for your vaccine. So please be patient, and please check your emails as there will be forms and schedules sent out as we coordinate the times with DKH. We strongly encourage all staff to take advantage of this opportunity to be vaccinated.

At this point, we need to know three things:

1) Do you want to receive the Vaccine?

2) Have you already received both shots?

3) Have you already registered in the VAMS or CVS or Walgreens systems? If you have, do you have an appointment already scheduled?

Please respond to Katrina Milanese at as soon as possible.

Some of you may have received an email from the Hartford Healthcare system; they have also been very proactive in answering the Governor’s request to get all School staff or individuals over 55 vaccinated. If you already have scheduled an appointment you can keep that appointment OR you can cancel it and get the vaccine here on March 4. The benefit of taking advantage of this clinic is that your second shot is already scheduled and guaranteed. Your choice. Either way you need to let us know.

Day Kimball needs an accurate count on the number of vaccines needed for March 4, so if you can respond to these questions as soon as possible, it would be greatly appreciated.

Note: Substitutes are also included in the opportunity for a vaccination and we are sending out emails to them as well, if you know of anyone that did not receive an email that should have, it may be that it went to their spam or we didn’t have the proper email, please have them contact the business office or send us an email so we can get forms out to them as well.

Please respond by Friday, February 26th or the latest March 1

FYI: The second shot is already scheduled for Thursday, April 1.

Here is a helpful article from today’s Washington Post that you might find useful.

The Washington Post

Pfizer, Moderna or maybe J&J? Right now, the best vaccine for you is the one you can get.

By Allyson Chiu

Feb. 25, 2021 at 1:00 p.m. UTC

The anticipated authorization of a third coronavirus vaccine has raised a new question for many Americans: Which shot should I get?

The answer, experts say, is whichever one you can.

If approved, the new Johnson & Johnson vaccine would join the Pfizer-BioNTech and Moderna vaccines, which are already being distributed nationwide. Food and Drug Administration reviews have found all three vaccines to be highly effective at preventing hospitalizations and deaths from covid-19. One of the main differences between them is that the Pfizer-BioNTech and Moderna vaccines require two shots given several weeks apart, while the Johnson & Johnson vaccine is a single shot, which might be more appealing to some people.

The FDA’s recently released review of Johnson & Johnson’s vaccine, which is expected to be authorized as early as this weekend, found that it was more than 80 percent effective at preventing severe illness in a large international clinical trial. But the review noted that the vaccine had lower efficacy among higher-risk older adults in the trial, a finding that experts hope will not discourage some people from taking it.

FDA review confirms safety and efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases

At this point in the vaccine rollout, it’s difficult to get any vaccine, much less a particular brand. And even if people could pick and choose now, experts say, that would likely hinder the goal of mass vaccination — which is to protect as many lives as quickly as possible.

“What we really are hoping for and what we want out of these vaccines is that we keep people out of the hospital and we keep people from dying,” said Joshua Barocas, an infectious-disease physician at Boston Medical Center. And, he added, of the Johnson & Johnson trial, “when we look at that data, that data is still robust.”

While the Johnson & Johnson vaccine was 42 percent effective at preventing moderate to severe illness among the group of older adults with comorbidities, the FDA emphasized that the statistical significance was uncertain and that none of those older adults died or needed to be hospitalized in the month after they were vaccinated. In fact, the vaccine completely prevented hospitalization and deaths among all trial participants who received the shot, providing a level of protection against serious illness that experts say is comparable to the Pfizer-BioNTech and Moderna vaccines, which were shown to be more than 90 percent effective in trials.

Your questions about coronavirus vaccines, answered

The lower efficacy rate of the Johnson & Johnson vaccine in the older subgroup “requires further evaluation going forward,” said William Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. But he, too, urged people to get whichever vaccine is available to them.

“Although cases, hospitalizations and deaths are coming down, there’s still a lot of community transmission in this country,” Moss said. “Until we really get that down, it’s really important that people get protected as early as possible.”

The more people who get vaccinated, “the lower everybody’s risk becomes, regardless of which vaccine you get,” Barocas said.

Can I choose my covid vaccine? Strong opinions on Oxford vs. Pfizer emerge in U.K.

If many Americans opted to wait for a preferred vaccine, it would not only leave more people at risk of developing a serious case of covid, but would also likely slow down the country’s vaccination program, which only recently started gaining steam after a tepid start.

“Most vaccine sites administer one [type of] vaccine on a given day,” Manisha Juthani, an infectious-disease specialist at Yale Medicine, wrote in an email. “If you go to a site and they are not administering a vaccine that you want, you will miss your opportunity and have to reschedule while the same thing could happen on another day.” Furthermore, you could be denying another person the opportunity to be vaccinated.

Given the current rates of vaccine development and production, experts estimate that most adults who want to be vaccinated should be able to do so by the summer, said Marc Siegel, an associate professor of medicine in the Division of Infectious Diseases at George Washington University.

And as more vaccines emerge and more research is done, recommendations regarding which vaccines are best for certain populations may emerge. With time, Siegel said, there will likely be clear public guidance from the Advisory Committee on Immunization Practices, an independent panel that advises the Centers for Disease Control and Prevention on the use of vaccines.

Vaccine terms explained: Efficacy vs. effectiveness, herd immunity and others

But until then, Barocas urged people to focus not on which vaccination you want, but on why you want one. And the answer, he said, should be that you want a vaccination because you don’t want to be hospitalized or die.

“Regardless of your risk group, how you slice it, that’s what these vaccines are doing,” he said. “They’re keeping you out of the hospital and keeping you alive.”